National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

Statutory Rules

1974 No. 126

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1973.*

WHEREAS it is provided by sub-section 101 (4) of the National Health Act 1953-1973 that a drug or medicinal preparation that was not a pharmaceutical benefit under the National Health Act 1953-1958 immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of the National Health Act 1953-1973 unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:

AND WHEREAS that Committee has recommended to the Minister that the following drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953-1973, namely the drugs and medicinal preparations specified in the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:

NOW THEREFORE I, THE GOVERNOR-GENERAL of Australia, acting with the advice of the Executive Council, hereby make the following Regulations under the National Health Act 1953-1973.

Dated this twenty-third day of July, 1974.

John R. Kerr

Governor-General.

By His Excellency’s Command,

 

Minister of State for Health.

____________

 

Amendments of the National Health (Pharmaceutical Benefits) Regulations 

Commencement.

1.These Regulations shall come into operation on 1 August 1974.

Writing of prescriptions.

2. Regulation 19 of the National Health (Phamaceutical Benefits) Regulations is amended—

(a) by omitting from paragraph (a) of sub-regulation (1) the words “ seven inches in length and five inches ” and substituting the words “ 18 centimetres in length and 12 centimetres ”; and

 

* Notified in the Australian Government Gazette on 30 July 1974.

  Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1964, Nos. 12, 57 and 135; 1965, Nos. 51, 151 and 152; 1966, Nos. 80 and 144; 1967, Nos. 67, 116 and 158; 1968, Nos. 44, 76, 88 and 146; 1969, Nos. 44, 107 and 185; 1970, Nos. 39, 94, 119 and 186; 1971, Nos. 44, 101, 136and 154; 1972, Nos. 32, 121 and 205; 1973, Nos. 15, 57, 139 and 229; and 1974, No. 37.

14340/74—Price 35c 10/12.7.1974

(b) by inserting in paragraph (h) of sub-regulation (1), after the words “ Fifth Schedule ”, the words “ or in a determination made by the Minister in pursuance of section 85 of the Act ”.

First, Second, Third, Fourth and Fifth Schedule.

3. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical benefits) Regulations are repealed and the following Schedules substituted:—

FIRST SCHEDULE Regulation 10

Drugs and Medicinal Preparations in The British Pharmacopoeia that are not to be supplied as or, except as specially provided, used in Pharmaceutical Benefits

1 Acetarsol

2 Acetomenaphthone

3 Acetomenaphthone Tablets

4 Acetrizoic Acid

5 Alcohol Dehydrated

6 Alcohol 95%

7 Allopurinol

8 Almond Oil

9 Aloes

10 Alprenolol Hydrochloride

11 Aluminium Hydroxide Tablets

12 Aluminium Phosphate Gel

13 Aluminium Phosphate Tablets

14 Aluminium Phosphate Gel Dried

15 Amethocaine Hydrochloride

16 Amodiaquine Tablets

17 Amphetamine Sulphate

18 Amphetamine Sulphate Tablets

19 Amylobarbitone Sodium Tablets

20 Antazoline Hydrochloride

21 Antazoline Tablets

22 Antimony Sodium Tartrate

23 Antimony Sodium Tartrate Injection

24 Apomorphine Hydrochloride

25 Apomorphine Injection

26 Arachis Oil

27 Aspirin Phenacetin and Codeine Tablets

28 Aspirin Phenacetin and Codeine Tablets Soluble

29 Azathioprine

30 Bacillus Calmette-Guerin Vaccine

31 Barium Sulphate

32 Beclomethasone Dipropionate

33 Belladonna Herb

34 Bendrofluazide

35 Benzhexol Hydrochloride

36 Benzyl Alcohol

37 Betamethasone Sodium Phosphate Tablets

38 Bethanidine Sulphate

39 Bisacodyl Suppositories

40 Bisacodyl Tablets

41 Bupivacaine Hydrochloride

42 Busulphan

43 Butobarbitone

44 Butylated Hydroxyanisole

45 Butylated Hydroxytoluene

46 Caffeine Hydrate

47 Calciferol Solution

48 Calcium Aminosalicylate

49 Camphor

50 Caraway

51 Carbamazepine

52 Carbenoxolone Sodium

53 Carbimazole

54 Carbon Dioxide

55 Carbromal

56 Cardamom Fruit

57 Cascara

58 Castor Oil

59 Catgut, Sterilised Surgical

60 Cellulose, Oxidised

61 Cetomacrogol 1000

62 Cetylpyridinium Chloride

63 Chlorambucil

64 Chlorcyclizine Hydrochloride

65 Chlordiazepoxide Capsules

66 Chlordiazepoxide Hydrochloride

67 Chlorhexidine Gluconate Solution

68 Chlorhexidine Hydrochloride

69 Chloroform

70 Chlormerodrin (187 Hg) Injection

71 Chloroquine Phosphate

72 Chloroquine Phosphate Injection

73 Chloroquine Sulphate

74 Chlorothiazide

75 Chlorotrianisene

76 Chlorotrianisene Capsules

77 Chlorphenesin

78 Chlorproguanil Hydrochloride

79 Chlorproguanil Tablets

80 Chlorpropamide

81 Chlorthalidone

82 Choline Theophyllinate Tablet

83 Cinchocaine Hydrochloride

84 Cinnamon

85 Clofibrate

86 Clomiphene Citrate

87 Clomiphene Tablets

88 Cochineal

89 Colchicine

90 Colchicum Corm

91 Colchicum Liquid Extract

92 Colchicum Tincture

93 Colistin Tablets

94 Colophony

95 Concentrated Peppermint Water

96 Coriander

97 Coriander Oil

98 Corticotrophin

99 Corticotrophin Injection

100 Corticotrophin Gelatin Injection

101 Corticotrophin Zinc Injection

102 Cortisone Acetate

103 Cresol

104 Crotamiton

105 Cyanocobalamin

106 Cyanocobalamin (77 Co)

107 Cyanocobalamin (87 Co)

108 Cyclizine Tablets

109 Cyclobarbitone Calcium

110 Cyclomethycaine Sulphate

First Schedule—continued

111 Cyclopenthiazide

112 Cyclopentolate Hydrochloride

113 Cyclopropane

114 Cycloserine

115 Cycloserine Tablets

116 Dapsone

117 Deoxycortone-Acetate

118 Deoxycortone Acetate Implants

119 Deoxycortone Acetate Injection

120 Dequalinium Acetate

121 Dequalinium Chloride

122 Desipramine Hydrochloride

123 Dexamphetamine Sulphate

124 Dextran 110 Injection

125 Dextromethorphan Hydrobromide

126 Dextromethorphan Tablets

127 Dextropropoxyphene Capsules

128 Dextropropoxyphene Napsylate

129 Dextrose

130 Diamorphine Hydrochloride

131 Diamorphine Injection

132 Diazepam Capsules

133 Dibromopropamidine Isethionate

134 Dichloralphenazone

135 Dichloralphenazone Tablets

130 Dichlorophen

137 Dichlorophen Tablets

138 Dichlorphenamide

139 Dicophane

140 Diethylcarbamazine Citrate

141 Diethylcarbamazine Tablets

142 Digitalis Leaf

143 Digitalis Prepared

144 Digitalis Tablets, Prepared

145 Digitoxin

146 Digitoxin Tablets

147 Dihydrocodeine Injection

148 Dihydrocodeine Tablets

149 Di-iodohydroxyquinoline Tablets

150 Diloxanide Furoate

151 Dilute Alcohols

152 Dimenhydrinate

153 Dimenhydrinate Injection

154 Dimenhydrinate Tablets

155 Dimercaprol

156 Dimethisterone Tablets

157 Diodone. Injection

158 Diphenhydramine Injection

159 Diphenoxylate Hydrochloride

160 Diphtheria Vaccine

161 Diphtheria and Tetanus Vaccine

162 Diphtheria, Tetanus and Pertussis Vaccine

163 Diphtheria, Tetanus and Poliomyelitis Vaccine

164 Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine

165 Dipipanone Hydrochloride

166 Dipipanone Injection

167 Dodecyl Gallate

168 Domlphen Bromide

169 Dried Human Albumin

170 Dydrogesterone

171 Dydrogesterone Tablets

172 Edrophonium Chloride

173 Edrophonium Injection

174 Eltor Vaccine

175 Emetine and Bismuth Iodide

176 Emetine Hydrochloride

177 Erythromycin

178 Erythromycin Estolate Capsules

179 Ethacrynic Acid

180 Ethambutol Hydrochloride

181 Ethambutol Tablets

182 Ethchlorvynol

183 Ether Anaesthetic

184 Ether Solvent

185 Ethionamide

186 Ethionamide Tablets

187 Ethisterone

188 Ethisterone Tablets

189 Ethopropazine Hydrochloride

190 Ethotoin

191 Ethyl Chloride

192 Ethyl Oleate

193 Ethylenediamine Hydrate

194 Eucalyptus Oil

195 Eugenol

196 Fenfluramine Hydrochloride

197 Fenfluramine Tablets

198 Ferric Citrate (86 Fe) Injection

199 Ferrous Fumarate

200 Ferrous Succinate Tablets

201 Fludrocortisone Acetate

202 Fluoxymesterone

203 Fractionated Coconut Oil

204 Fractionated Palm Kernel Oil

205 Gallamine Triethiodide

206 Gallamine Injection

207 Gelatin Sponge, Absorbable

208 Gentamicin Sulphate

209 Gentian

210 Ginger

211 Gold (188 Au) Injection

212 Griseofulvin

213 Guanethidine Sulphate

214 Halothane

215 Helium

216 Heparin

217 Hexachlorophane

218 Hexylresorcinol

219 Histamine Acid Phosphate

220 Histamine Acid Phosphate Injection

221 Human Albumin

222 Human Albumin Fraction (Saline)

223 Human Albumin Fraction (Saline), Dried

224 Human Antihaemophilic Fraction, Dried

225 Human Blood, Whole

226 Human Fibrinogen, Dried

227 Human Fibrinogen for Isotopic Labelling, Dried

228 Human Normal Immunoglobulin

Injection

229 Human Plasma, Dried

230 Human Red Blood Corpuscles, Concentrated

231 Human Serum, Dried

232 Human Thrombin, Dried

233 Hydrochlorothiazide

234 Hydrocortisone Hydrogen Succinate

235 Hydrocortisone Ointment

236 Hydroflumethiazide

237 Hydroxocobalamin

238 Hydroxychloroquine Sulphate

239 Hydroxyprogesterone Hexanoate

240 Hydroxyprogesterone Injection

First Schedule—continued

241 Hyoscine Injection

242 Hyoscine Eye Ointment

243 Hyoscine Tablets

244 Hyoscyamus

245 Indigo Carmine

246 Indomethacin

247 Influenza Vaccine

248 Industrial Methylated Spirit

249 Intracutaneous Typhoid-paratyphoid A & B Vaccine

250 Inulin

251 lnulin Injection

252 Iodinated (124 I) Human Albumin Injection

253 Iodinated (131 I) Human Albumin Injection

254 Iodipamide Meglumine Injection

255 Iodised Oil Fluid Injection

256 Iopanoic Acid

257 Iopanoic Acid Tablets

258 Iophendylate Injection

259 Iothalamic Acid

260 Ipecacuanha

261 Ipecacuanha, Prepared

262 Isocarboxazid

263 Isocarboxazid Tablets

264 Isoniazid

265 Isopropyl Alcohol

266 Laevulose

267 Lemon Peel, Dried

268 Levallorphan Injection

269 Levodopa

270 Levorphanol Injection

271 Levorphanol Tablets

272 Levorphanol Tartrate

273 Lignocaine and Adrenaline Injection

274 Liothyronine Sodium

275 Liquorice

276 Lithium Carbonate

277 Lymecycline

278 Lymecycline Capsules

279 Lymecycline and Procaine Injection

280 Macrisalb (13 I) Injection

281 Macrogol 300

282 Macrogol 1540

283 Macrogol 4000

284 Magnesium Stearate

285 Maize Oil

286 Male Fern

287 Male Fern Extract

288 Maleic Acid

289 Mannitol

290 Measles Vaccine (Live Attenuated)

291 Mefenamic Acid

292 Mefenamic Acid Capsules

293 Meglumine Diatrizoate Injection

294 Meglumine Iothalamate Injection

295 Melarsoprol Injection

296 Melphalan

297 Melphalan Injection

298 Mepacrine Hydrochloride

299 Mepacrine Tablets

300 Mephentermine Injection

301 Mephentermine Sulphate

302 Meprobamate

303 Meprobamate Tablets

304 Mepyramine Injection

305 Mepyramine Maleate

306 Mepyramine Tablets

307 Mercaptopurine

308 Mersalyl Acid

309 Metaraminol Tartrate

310 Methandienone

311 Methohexitone Injection

312 Methoin

313 Methoserpidine

314 Methoserpidine Tablets

315 Methoxyflurane

316 Methylcellulose 450

317 Methylamphetamine Hydrochloride

318 Methylamphetamine Injection

319 Methylamphetamine Tablets

320 Methyldopa

321 Methylergometrine Maleate

322 Methylprednisolone Tablets

323 Methylthiouracil

324 Methylthiouracil Tablets

325 Methyprylone

326Methyprylone Tablets

327 Metronidazole

328 Metyrapone

329 Morphine Sulphate Tablets

330 Nalorphine Hydrobromide

331 Nandrolone Decanoate

332 Nandrolone Phenylpropionate

333 Neostigmine Bromide

334 Nialamide

335 Nialamide Tablets

336 Niclosamide

337 Nicotinic Acid

338 Nicoumalone

339 Nikethamide

340 Nikethamide Injection

341 Nitrazepam

342 Nitrous Oxide

343 Norethandrolone

344 Norethandrolone Tablets

345 Noscapine

346 Novobiocin Calcium

347 Novobiocin Sodium

348 Novobiocin Tablets

349 Nux Vomica

350 Octyl Gallate

351 Oestradiol Benzoate

352 Oestradiol Benzoate Injection

353 Olive Oil

354 Opium

355 Opium, Powdered

356 Orange Peel, Dried Bitter

357 Orciprenaline Injection

358 Orphenadrine Hydrochloride

359 Oxygen

360 Oxyphenbutazone

361 Oxyphenbutazone Tablets

362 Oxyphencyclimine Hydrochloride

363 Oxytetracycline Tablets

364 Oxytocin Tablets

365 Paramethadione

366 Penicillamine

367 Penicillamine Hydrochloride

368 Pentagastrin

369 Pentagastrin injection

370 Pentamidine Isethionate

371 Pentamidine Injection

372 Pentolinium Tartrate

373 Peppermint Oil

374 Percutaneous Bacillus Calmette - Guerin vaccine

First Schedule—continued

375 Perphenazine

376 Perphenazine Tablets

377 Pethidine Tablets

378 Phenacetin

379 Phenazocine Hydrobromide

380 Phenazocine Injection

381 Phenazocine Tablets

382 Phenelzine Sulphate

383 Phenelzine Tablets

384 Phenindamine Tartrate

385 Phenindione

386 Phenmetrazine Hydrochloride

387 Phenmetrazine Tablets

388 Phenol and Glycerol Injection

389 Phenolphthalein Tablets

390 Phenoxybenzamine Capsules

391 Phenoxybenzamine Hydrochloride

392 Phenoxymethylpenicillin

393 Phenoxymethylpenicillin Potassium

394 Phentolamine Mesylate

395 Phentolamine Injection

396 Phenylephrine Injection

397 Phenylpropanolamine Hydrochloride

398 Phosphoric Acid

399 Phytomenadione Tablets

400 Piperazine Citrate

401 Piperazine Phosphate Tablets

402 Poldine Methylsulphate

403 Poliomyelitis Vaccine (Inactivated)

404 Poliomyelitis Vaccine (Oral)

405 Potassium Bromide

406 Potassium Chloride and Dextrose Injection

407 Potassium Chloride and Sodium Chloride Injection

408 Potassium Hydroxide

409 Potassium Nitrate

410 Practolol

411 Prednisolone Pivalate

412 Prednisolone Pivalate Injection

413 Prilocaine Hydrochloride

414 Primaquine Phosphate

415 Probenecid

416 Procainamide Tablets

417 Procaine and Adrenaline Injection

418 Prochlorperazine Maleate

419 Prochlorperazine Mesylate

420 Procyclidine Hydrochloride

421 Progesterone

422 Progesterone Injection

423 Proguanil Hydrochloride

424 Promazine Hydrochloride

425 Promazine Injection

426 Promazine Tablets

427 Promethazine Theoclate

428 Propanidid

429 Propicillin Potassium

430 Propicillin Tablets

431 Propranolol Hydrochloride

432 Propyl Gallate

433 Propyliodone

434 Propyliodone Injection

435 Propyliodone Oily Injection

436 Propylthiouracil

437 Pyrazinamide

438 Pyridostigmine Bromide

439 Pyrimethamine

440 Pyroxylin

441 Quillaia

442 Quinine Bisulphate

413 Quinine Dihydrochloride

444 Quinine Dihydrochloride Injection

445 Quinine Sulphate

416 Rabies Antiserum

447 Rabies Vaccine

448 Rubella Vaccine (Live Attenuated)

449 Saccharin

450 Saccharin Sodium

451 Secbutobarbitone

452 L-Selenomethionine (78 Se) Injection

453 Senna Fruit

454 Silver Nitrate, Toughened

455 Slow Lithium Carbonate Tablets

456 Slow Orphenadrine Citrate Tablet

457 Smallpox Vaccine, Dried

458 Soda Lime

459 Sodium Acetrizoate Injection

460 Sodium Aurothiomalate

461 Sodium Bicarbonate Compound Tablets

462 Sodium Bromide

463 Sodium Calciumedetate

404 Sodium Chromate (51 Cr) Solution

405 Sodium Citrate Tablets

466 Sodium Diatrizoate

467 Sodium Diatrizoate Injection

468 Sodium Fluoride

469 Sodium Fusidate Capsules

470 Sodium Hydroxide

471 Sodium Iodide (131 I) Injection

472 Sodium Iodide (131 I) Solution

473 Sodium Iodide (131 I) Solution

474 Sodium Iodohippurate (131 I) Injection

475 Sodium Iothalamate Injection

476 Sodium Lauryl Sulphate

477 Sodium Methyl Hydroxybenzoate

478 Sodium Pertechnetate (Tc) Injection

479 Sodium Phosphate (52 P) Injection

480 Sodium Propyl Hydroxybenzoate

481 Sodium Stibogluconate

482 Sodium Stibogluconate Injection

483 Sorbitol Injection

484 Spironolactone

485 Sterilisable Maize Starch

486 Stramonium

487 Strong Potassium Chloride Solution

488 Sulphadimethoxine

489 Sulphadimidine Injection

490 Sulphadimidine Sodium

491 Sulphamethoxydiazine

492 Sulphamethoxypyridazine

493 Sulphapyridine

494 Sulphinpyrazone

495 Sulphobromophthalein Sodium

496 Sulphomyxin Injection

497 Sulphomyxin Sodium

498 Sulthiame

499 Suxamethonium Bromide

500 Suxamethonium Bromide Injection

501 Suxamethonium Chloride

502 Suxamethonium Chloride Injection

503 Testosterone

504 Testosterone Phenylpropionate Injection

505 Tetanus Vaccine

506 Tetanus and Pertussis Vaccine

First Schedule—continued

507 Tetrachloroethylene

508 Tetrachloroethylene Capsules

509 Tetracycline Tablets

510 Thiambutosine

511 Thiomersal

512 Thiopentone Sodium

513 Thiopentone Injection

514 Thioridazine Hydrochloride

515 Thyroid

516 Thyroxine Sodium

517 Tolnaftate

518 Tolazoline Hydrochloride

519 Tolazoline Tablets

520 Tolbutamide

521 Tranylcypromine Sulphate

522 Tranylcypromine Tablets

523 Triamterene Capsules

524 Trichloroethylene

525 Triclofos Tablets

526 Trimipramine Maleate

527 Tropicamide

528 Tuberculin, Old

529 Tuberculin Purified Protein Derivative

530 Tubocurarine Chloride

531 Tubocurarine Injection

532 Turpentine Oil

533 Typhoid and Tetanus Vaccine

534 Typhoid-paratyphoid A and B vaccine

535 Typhoid-paratyphoid A and B and Tetanus Vaccine

536 Typhoid-paratyphoid A and B and Cholera Vaccine

537 Undecenoic Acid

538 Urea

539 Urea Injection

540 Vinyl Ether

541 Vitamin A Ester Concentrate

542 Xenon (133 Xe) Injection

543 Xylose

544 Yellow Fever Vaccine

545 Zinc Undecenoate

546 Zinc Undecenoate Ointment

SECOND SCHEDULE Regulation 10 (3)

Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
1	Acepifylline..........................................	—
2	Acetylsulphafurazole.........................	—
3	Acetylcysteine......................................	—
4	Acrylic Resin........................................	—
5	Adrenaline Hydrochloride.................	—
6	Albumaid XP........................................	—
7	Alginic Acid Compound...................	—
8	Aluminium Sodium Silicate..............	—
9	Amino Acids.........................................	Amino Acids with Sorbitol
Amino Acids with Sorbitol and Alcohol
10	Aminocaproic Acid.............................	—
11	Aminogran............................................	—
12	Amphotericin B...................................	Tetracycline, B.P.C., with buffering agent and Amphotericin B
13	Ampicillin..............................................	—
14	Ampicillin Trihydrate.........................	Purified Water, B.P., with Ampicillin Trihydrate
15	Antazoline Sulphate...........................	Naphazoline Nitrate with Antazoline Sulphate
16	Ascorbic Acid......................................	Vitamin A with Thiamine Hydrochloride, Riboflavine Nicotinamide, Vitamin D and Ascorbic Acid
Ferrous Sulphate mixture and Ferrous Sulphate mixture C.F. of the Australian Pharmaceutical Formulary
Ferrous Sulphate mixture Prescribers’’ List
Ferrous Sulphate mixture Prescribers’’ List Children’s Section
17	Attapulgite............................................	Dihydrostreptomycin Sulphate with Pectin, Dried Aluminium Hydroxide Gel and Attapulgite
18	Bacitracin.............................................	Neomycin Sulphate with Polymyxin B Sulphate and Bacitracin
19	Bacitracin Zinc.....................................	Neomycin Undecenoate with Bacitracin Zinc Polymyxin B Sulphate with Neomycin Sulphate and Bacitracin Zinc
20	“ BANISH ”.........................................	—
21	Belladonna Herb, Prepared................	Phenobarbitone with Belladonna Herb, Prepared
22	Belladonna, Dry Extract....................	Phenolphthalein with Aloin, Strychnine. B.P.C. 1959, Ipecacuanha and Dry Extract of Belladonna
23	Betamethasone....................................	Betamethasone Acetate with Betamethasone
24	Betamethasone Acetate.....................	Betamethasone with Betamethasone Acetate
25	Betamethasone Sodium Phosphate.	—
26	Betamethasone Phosphate................	—
27	Bisacodyl..............................................	Dioctyl Sodium Sulphosuccinate, B.P.C., with Bisacodyl
28	Brompheniramine Maleate...............	—
29	Calciferol..............................................	—
30	Calcium Di-Oxytetracycline..............	—
31	Calcium Lactate-Gluconate..............	Calcium Carbonate, B.P., with Calcium Lactate-Gluconate
32	Capsicum Oleoresin............................	Cascara Dry Extract with Phenolphthalein, Sodium Tauroglycocholate, B.P.C. 1954, and Capsicum Oleoresin
33	Carbachol.............................................	Hypromellose 4500 with Carbachol
34	Carbinoxamine Maleate....................	—
35	Cascara Dry Extract...........................	Phenolphthalein with Capsicum Oleoresin, Sodium Tauroglycocholate, B.P.C. 1954, and Cascara Dry Extract
36	Ceratonia, B.P.C. 1949......................	—
37	Chloramine, B.P.C..............................	—
38	Chloramphenicol.................................	Polymyxin B Sulphate with Chloramphenicol
39	Chloramphenicol Palmitate, B.P.C.	—
40	Chloramphenicol Stearate.................	—
41	Chlorhexidine Gluconate...................	—
42	Chlorpheniramine Maleate...............

—

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
43	Chlorpromazine Hydrochloride	—
44	Choline Theophyllinate.....................	Guaiphenesin with Choline Theophyllinate
45	Clemastine Hydrogen Fumarate......	—
40	Clemizole Tannate.............................	—
47	Cloxacillin Sodium.............................	Purified Water, B.P., with Cloxacillin Sodium
48	Colistin Sulphate.................................	Neomycin Sulphate with Colistin Sulphate
49	Cortisone Acetate................................	—
50	Cyclizine Hydrochloride....................	Ergotamine Tartrate with Caffeine and Cyclizine Hydrochloride
51	Cyproheptadine Hydrochloride........	—
52	Danthron...............................................	Dioctyl Sodium Sulphosuccinate, B.P.C., with Danthron
53	Demecarium Bromide........................	—
54	Demeclocycline Hydrochloride........	Nystatin with Demeclocycline Hydrochloride
55	Dexamethasone...................................	Framycetin Sulphate with Gramicidin and Dexamethasone
56	Dexamethasone Metasulphobenzoate	Framycetin Sulphate with Gramicidin and Dexamethasone Metasulphobenzoate
57	Dexchlorpheniramine Maleate.........	—
58	Dextropropoxyphene Hydrochloride	Paracetamol with Dextropropoxyphene Hydrochloride
59	Dextroso Polymer................................	—
60	Diazepam.............................................	—
61	Dicyclomine Hydrochloride	Doxylamine Succinate with Pyridoxine Hydrochloride and Dicyclomine Hydrochloride
62	Dienoestrol............................................	—
63	Digoxin..................................................	—
64	Dihydrocodeine Tartrate....................	—
65	Dihydrostreptomycin Sulphate, B.P. 1958.......................................................	Attapulgite with Pectin, Dried Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958
Kaolin with Pectin, Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958
66	Dihydrotachysterol.............................	—
67	Dimethicone, B.P.C............................	—
68	Dimethisterone.....................................	Ethinyloestradiol with Dimethisterone
69	Dioctyl Sodium Sulphosuccinate, B.P.C.................................................................	Bisacodyl with Dioctyl Sodium Sulphosuccinate, B.P.C.
Danthron with Dioctyl Sodium Sulphosuccinate, B.P.C.
70	Diphenhydramine Hydrochloride.....	Ergotamine Tartrate with Caffeine Citrate and Diphenhydramine Hydrochloride
71	Diphenylpyraline Hydrochloride......	—
72	Diphtheria Vaccine Adsorbed...........	Diphtheria and Tetanus Vaccine Adsorbed
Diphtheria, Tetanus and Pertussis Vaccine Adsorbed
73	Doxycycline Hydrochloride..............	—
74	Doxylamine Succinate.......................	Dicyclomine Hydrochloride with Pyridoxine Hydrochloride and Doxylamine Succinate
75	Ecothiopate Iodide..............................	—
76	Ergometrine Maleate..........................	Oxytocin with Ergometrine Maleate
77	Ergotamine Tartrate...........................	Caffeine with Ergotamine Tartrate
Caffeine with Cyclizine Hydrochloride and Ergotamine Tartrate
Caffeine Citrate with Diphenhydramine Hydrochloride and Ergotamine Tartrate
Caffeine with Meclozine Hydrochloride and Ergotamine Tartrate
78	Erythromycin Estolate.......................	—
79	Erythromycin Stearate.......................	—

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
80	Ethinyloestradiol.................................	Dimethisterone with Ethinyloestradiol
Ethynodiol Diacetate with Ethinyloestradiol
Megestrol Acetate with Ethinyloestradiol
Norethisterone Acetate with Ethinyloestradiol
Norgestrel with Ethinyloestradiol
81	Ethosuximide.......................................	—
82	Ethynodiol Diacetate..........................	Ethinyloestradiol with Ethynodiol Diacetate
Mestranol with Ethynodiol Diacetate
83	Ferric Hydroxide.................................	—
84	Ferrous Aminoacetosulphate............	—
85	Ferrous Succinate................................	—
86	Fluclorolone Acetonide......................	—
87	Fluocinolone Acetonide.....................	—
88	Fluocortolone Hexanoate..................	Fluocortolone Pivalate with Fluocortolone Hexanoate
89	Fluocortolone Pivalate.......................	Fluocortolone Hexanoate with Fluocortolone Pivalate
90	Fluphenazine Hydrochloride.............	—
91	Flurandrenolone..................................	—
92	Folic Acid.............................................	Ferrous Sulphate (Dried), B.P., with Folic Acid, B.P.
93	Framycetin Sulphate	Light Kaolin or Light Kaolin (Natural), with Framycetin Sulphate
Dexamethasone with Framycetin Sulphate and Gramicidin
Gramicidin and Dexamethasone Metasulphobenzoate with Framycetin Sulphate
94	Fusidic Acid.........................................	—
95	Galactomin, Formula No. 17............	—
96	Galactomin, Formula No. 19............	—
97	Glucose and Ketone Indicator	—
98	Glucose Indicator, Blood...................	—
99	Glucose Indicator, Urine....................	—
100	Goat’s Milk, Dehydrated...................	—
101	Goat’s Milk...........................................	—
102	Gramicidin............................................	Polymyxin 11 Sulphate with Neomycin Sulphate and Gramicidin
Neomycin Sulphate with Thonzonium Bromide, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Gramicidin
Framycetin Sulphate with Dexamethasone and Gramicidin
Framycetin Sulphate with Dexamethasone Metasulphobenzoate and Gramicidin
Neomycin Sulphate with Nystatin, Triamcinolone Acetonide and Gramicidin
103	Guaiphenesin, B.P.C...........................	Theophylline with Guaiphenesin, B.P.C.
104	Hexamine Mandelate.........................	—
105	Hydrocortisone....................................	Polymyxin B Sulphate with Neomycin Sulphate Hydrocortisone
Neomycin Sulphate with Hydrocortisone
Natamycin with Neomycin Sulphate and Hydrocortisone
106	Hydrocortisone Acetate.....................	Neomycin Sulphate with Hydrocortisone Acetate
Neomycin Sulphate with Gramicidin, Thonzonium Bromide, Thonzylamine Hydrochloride and Hydro cortisone Acetate
Oxytetracycline Hydrochloride and Hydrocortisone Acetate
107	Hyoscine Hydrobromide...................	Hypromellose 4500 with Hyoscine Hydrobromide
Papaveretum with Hyoscine Hydrobromide
108	Idoxuridine...........................................	—
109	Ipecacuanha.........................................	Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine, B.P.C. 1959, and Ipecacuanha
110	“ ISOMIL”............................................	—
111	Isoprenaline Hydrochloride...............	—
112	Kanamycin Sulphate, B.P.C..............	—
113	“ KETOVITE ” Liquid.......................	—

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
114	Lauryl Dimethylbenzyl Ammonium Chloride	“ TERIC N8 ” with Lauryl Dimethylbenzyl Ammonium Chloride
115	Levallorphan Tartrate.................	Pethidine Hydrochloride with Levallorphan Tartrate
116	Lincomycin Hydrochloride........	—
117	Locasol...........................................	—
118	Lofenalac......................................	—
119	Lynoestrenol.................................	Mestranol with Lynoestrenol
120	Lypressin........................................	—
121	Magnesium Aluminium Hydroxide......................................	—
122	Magnesium Chloride....................	Sodium Chloride with Ammonium Chloride, Potassium Chloride and Magnesium Chloride
Sodium Chloride with Potassium Chloride, Sodium Lactate and Magnesium Chloride
Sodium Chloride with Sodium Acetate, Sodium Gluconate, Potassium Chloride and Magnesium Chloride
123	Magnesium Hydroxide, B.P.C... .	Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C.
Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine
Aluminium Hydroxide Gel Dried with Magnesium Hydroxide, B.P.C.
Aluminium Hydroxide Gel Dried with Magnesium Trisilicate and Magnesium Hydroxide, B.P.C.
124	Mebhydrolin Napadisylate, B.P.C...........................................	—
125	Meclozine Hydrochloride...........	Ergotamine Tartrate with Caffeine and Meclozine Hydrochloride
126	Medrysone.....................................	—
127	Megestrol Acetate........................	Ethinyloestradiol with Megestrol Acetate
128	Meglumine.....................................	Theophylline with Meglumine
129	Mestranol.......................................	Ethynodiol Diacetate with Mestranol
Lynoestrenol with Mestranol
Norethisterone with Mestranol
Norethynodrel with Mestranol
130	Methacycline Hydrochloride......	—
131	Methdilazine Hydrochloride......	—
132	Methylprednisolone.....................	—
133	Morphine Tartrate........................	Morphine Tartrate with Tacrine
134	Nalidixic Acid, B.P.C..................	—
135	Naphazoline Nitrate.....................	Naphazoline Nitrate with Antazoline Sulphate
136	Natamycin.....................................	Neomycin Sulphate with Hydrocortisone and Natamycin
137	Neomycin Sulphate.....................	Hydrocortisone Acetate with Neomycin Sulphate
Hydrocortisone with Neomycin Sulphate
Colistin Sulphate with Neomycin Sulphate
Light Kaolin or Light Kaolin (Natural) with Neomycin Sulphate
Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate
Polymyxin B Sulphate with Gramicidin and Neomycin Sulphate
Polymyxin B Sulphate with Hydrocortisone and Neomycin Sulphate
Bacitracin with Polymyxin B Sulphate and Neomycin Sulphate
Thonzonium Bromide with Thonzylamine Hydrochloride, Hydrocortisone Acetate, Gramicidin and Neomycin Sulphate
Gramicidin with Nystatin, Triamcinolone Acetonide and Neomycin Sulphate
Natamycin with Hydrocortisone and Neomycin Sulphate
138	Neomycin Undecenoate.............	Bacitracin Zinc with Neomycin Undecenoate

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
139	Neostigmine Methylsulphate	—
140	Nicotinamide.........................................	Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D
141	Nitrofurantoin.......................................	—
142	Noradrenaline Acid Tartrate..............	—
143	Norethisterone.......................................	Mestranol with Norethisterone
144	Norethisterone Acetate.......................	Ethinyloestradiol with Norethisterone Acetate
145	Norethynodrel.......................................	Mestranol with Norethynodrel
146	Norgestrel...............................................	Ethinyloestradiol with Norgestrel
147	Nortriptyline Hydrochloride...............	—
148	Nystatin..................................................	Tetracycline, B.P.C. with a buffering agent and Nystatin
Demeclocycline with Nystatin
Tetracycline Hydrochloride with Nystatin
Gramicidin with Neomycin Sulphate, Triamcinolone Acctonide and Nystatin
Oxytetracycline Dihydrate with Nystatin
149	Nutramigen............................................	—
150	Octatropine Methylbromide...............	—
151	Orciprenaline Sulphate.......................	—
152	Oxytetracycline Dihydrate.................	Nystatin with Oxytetracycline Dihydrate
153	Oxytetracycline Hydrochloride, B.P	Polymyxin B Sulphate with Oxytetracycline Hydrochloride, B.P.
Hydrocortisone Acetate with Oxytetracycline Hydrochloride, B.P.
154	Oxethazaine..........................................	Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine
155	Oxytocin................................................	Ergometrine Maleate with Oxytocin
156	Pancrceatin............................................	—
157	Pancrecatin Enzyme, 4 times U.S.N.F.XIII strength......................	—
158	Papaveretum, B.P.C.............................	Hyoscine Hydrobromide with Papaveretum, B.P.C.
159	Penicillin, Benethamine, B.P.C.........	Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin
160	Penicillin, Benzathine.........................	Procaine Penicillin with Potassium Penicillin and Benzathine Penicillin
161	Penicillin, Benzyl.................................	Procaine Penicillin with Benzyl Penicillin
162	Penicillin, Phenoxymethyl (Benzathine, Hydrabamine, or Calcium Salt)....................................	—
163	Penicillin, Potassium...........................	Benzathine Penicillin with Procaine Penicillin and Potassium Penicillin
164	Penicillin, Procaine..............................	Benethamine Penicillin, B.P.C. with Sodium Penicillin and Procaine Penicillin
Benzathine Penicillin with Potassium Penicillin and Procaine Penicillin
Benzyl Penicillin with Procaine Penicillin
165	Penicillin, Sodium................................	Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin
166	Pentobarbitone.....................................	Barbitone Sodium with Phenobarbitone Sodium and Pentobarbitone
167	Pericyazine............................................	—
168	Pertussis Vaccine.................................	Diphtheria, Tetanus and Pertussis Vaccine Adsorbed
169	Pethidine Hydrochloride.....................	Levallorphan Tartrate with Pethidine Hydrochloride
170	Phenethicillin Benzathine..................	—
171	Phenethicillin Potassium....................	Purified Water, B.P., with Phenethicillin Potassium
172	Pheniramine Maleate..........................	—
173	Phenytoin, B.P.C..................................	—
174	Pholcodine.............................................	—
175	Pipenzolate Bromide...........................	—
176	Pituitary (Posterior Lobe), Powdered, B.P.C...................................................	—
177	“PK AID I”............................................	—
178	“PK AID II”..........................................	—

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
179	Plasma Substitute (Polypeptide)	—
180	Polyisobutylene....................................	—
181	Polymyxin B Sulphate........................	Chloramphenicol with Polymyxin B Sulphate
Oxytetracycline Hydrochloride with Polymyxin B Sulphate
Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate
Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin
Propylene Glycol with Acetic Acid and Polymyxin D Sulphate
Neomycin Sulphate with Hydrocortisone and Polymyxin B Sulphate
Bacitracin with Neomycin Sulphate and Polymyxin B Sulphate
Lignocaine Hydrochloride with Propylene Glycol and Polymyxin B Sulphate
182	Polyvinyl Alcohol.................................	Pilocarpine Nitrate and Polyvinyl Alcohol
183	Polyvinylpyrrolidone and Vinyl Acetate Copolymer	Polyvinylpyrrolidone and Vinyl Acetate Copolymer with Benzocaine, B.P.
184	Prednisolone..........................................	—
185	Prednisolone Acetate...........................	Prednisolone Acetate with Phenylephrine Hydrochloride, B.P.
186	Prednisolone Sodium Phosphate	—
186A	“ PREGESTIMIL ”..............................	—
187	Primidone...............................................	—
188	Promethazine Hydrochloride	—
189	Pseudoephedrine Hydrochloride	—
190	Pyrantel Embonate..............................	—
191	Pyridoxine Hydrochloride..................	Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxins Hydrochloride
192	“ PROSOBEE ”....................................	—
193	Riboflavine............................................	Vitamin A with Thiamine Hydrochloride, Nicotinamide, Ascorbic Acid, Vitamin D and Riboflavine
194	Salbutamol............................................	—
195	Silver Nitrate, Toughened..................	—
196	“ SOBEE ”.............................................	—
197	Sodium Acetate....................................	Sodium Chloride with Potassium Chloride, Magnesium Chloride, Sodium Gluconate and Sodium Acetate
198	Sodium Acid Citrate............................	—
199	Sodium Gluconate...............................	Sodium Chloride with Sodium Acetate, Potassium Chloride, Magnesium Chloride and Sodium Gluconate
200	Sodium Lactate....................................	Potassium Chloride with Magnesium Chloride, Sodium Chloride and Sodium Lactate
Potassium Chloride with Anhydrous Dextrose and Sodium Lactate
201	Sodium Tauroglycocholate, B.P.C. 1954	Cascara Dry Extract with Phenolphthalein, Capsicum Oleoresin and Sodium Tauroglycocholate, B.P.C. 1954
202	Sorbitol...................................................	Amino Acids with Sorbitol
Amino Acids with Sorbitol and Alcohol
203	“ SOYALAC ”......................................	—
204	Sterculia.................................................	—
205	Strychnine, B.P.C. 1959.....................	Phenolphthalein with Aloin, Dry Extract of Belladonna, Ipecacuanha and Strychnine, B.P.C. 1959
206	Sulphafurazole.....................................	—
207	Sulphamethizole...................................	—
208	Sulphamethoxazole	Trimethoprim with Sulphamethoxazole
209	Sulphaphenazole, B.P.C......................	—
210	Surgical Cement...................................	—
211	Surgical Cement Solvent....................	—

 

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
212	Tacrine..................................................	Morphine Sulphate with Tacrine
Morphine Tartrate with Tacrine
	213	Terbutaline Sulphate..........................
214	“ TERIC N8 ”......................................	Lauryl Dimethylbenzyl Ammonium Chloride with “ TERIC N8 ”
215	Testosterone Decanoate....................	Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate
216	Testosterone Isoenproate..................	Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isoenproate
Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate
217	Testosterone Phenylpropionate	Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate
Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate
218	Testosterone Propionate....................	Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate
Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate
219	Tetanus Vaccine Adsorbed................	Diphtheria and Tetanus Vaccine Adsorbed
Diphtheria, Pertussis and Tetanus Vaccine Adsorbed
220	Tetracycline B.P.C..............................	Tetracycline, B.P.C. with a buffering agent
Tetracycline, B.P.C. with a buffering agent and Amphotericin B
Tetracycline, B.P.C. with a buffering agent and Nystatin
221	Tetracycline Hydrochloride...............	Tetracycline Hydrochloride with Nystatin
Procaine Hydrochloride with Tetracycline Hydrochloride
222	Thiamine Hydrochloride....................	Riboflavine with Nicotinamide, Ascorbic Acid, Vitamin A, Vitamin D and Thiamine Hydrochloride

223	Thioridazine.........................................	—
224	Thiotepa................................................	—
225	Thonzonium Bromide........................	Neomycin Sulphide with Gramicidin, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Thonzonium Bromide
226	Thonzylamine Hydrochloride	Neomycin Sulphate with Gramicidin, Hydrocortisone Acetate, Thonzonium Bromide and Thonzylamine Hydrochloride
227	Tiemonium Iodide..............................	—
228	Triamcinolone Acetonide..................	Gramicidin with Neomycin Sulphate, Nystatin and Triamcinolone Acetonide
229	Triclofos Sodium.................................	—
230	Trifluoperazine Hydrochloride	—
231	Triglycerides Oil, Medium Chain	—
232	Triglyde.................................................	—
233	Trimeprazine Tartrate, B.P.C............	—
234	Trimethoprim.......................................	Trimethoprim with Sulphamethoxazole
235	Triprolidine Hydrochloride...............	—
230	Viprynium Embonate........................	—
237	Vitamin A.............................................	Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin D and Vitamin A
138	Vitamin D.............................................	Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin A and Vitamin D
239	“ ZERODOR ”.....................................	—
240	“ ZOFF ”...............................................	—

 

THIRD SCHEDULE Regulation 11

Drugs and Medicinal Preparation Additional to the Drugs and Medicinal Preparation in the British Pharmacopoeia

1 Acepifylline

2 Acetazolamide Sodium

3 Acetohexamide

4 Acetylcholine Chloride

5 Acetylcysteine

6 Acetylsulphafurazole

7 Acidified Golden Syrup, A.P.F. 1955

8 Acriflavine, B.P.C. 1963

9 Acrylic Resin.

10 Adrenaline. Hydrochloride

11 Albumaid XI

12 Alginic Acid Compound

13 Aloin, B.P.C.

14 Almond Oil Volatile Bitter, B.P.C. 1959

15 Aloxiprin

16 Aluminium Acetate Solution, B.P.C.

17 Aluminium Aspirin

18 Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex

19 Aluminium Sodium Silicate

20 Amantadine Hydrochloride

21 Amaranth, B.P.C. 1954

22 Ambenonium Chloride

23 Amiloride Hydrochloride

24 Aminacrine Hydrochloride, B.P. 1968

25 Amino Acids

26 Aminogran

27 Aminosalicylic Acid

28 Amitriptyline Embonate, B.P.C.

29 Ammonia Aromatic Spirit, B.P.C.

30 Ammonia Solution, Strong, B.P.C.

31 Ammonium Acetate Solution, Strong, B.P.C.

32. Ammonium Bicarbonate, B.P.C.

33 Amphotericin B

34 Angiotensin Amide

35 Antazoline Sulphate

36 Anti-Hemophilic Factor of Animal Origin

37 Atropine, B.P.C.

38 Attapulgite

39 Bacitracin, B.P. 1968

40 “ BANISH ”

41 Benzalkonium Chloride

42 Benzoin Compound Tincture, B.P.C.

43 Betahistine Hydrochloride

44 Betamethasone Acetate

45 Betamethasone Phosphate

46 Bethanechol Chloride

47 Black Snake Antivenene

48 Biperiden Hydrochloride

49 Bismuth Subgallate, B.P.C.

50 Brompheniramine Maleate

51 Brown Snake Antivenene

52 Buchu Concentrated Infusion, B.P.C. 1954

53 Cade Oil, B.P.C.

54 Caffeine and Sodium Benzoate, B.P.C. 1954

55 Caffeine Citrate, B.P.C. 1959

55A Calcitonin

56 Calcium Di-Oxytetracycline

57 Calcium Folinate

58 Calcium Gluconogalactogluconate

59 Calcium Lactate-Gluconate

60 Capsicum Ointment, B.P.C.

61 Capsicum Oleoresin, B.P.C.

62 Carbinoxamine Maleate

63 Cardamom Aromatic Tincture, B.P.C.

64 Cascara Elixir. B.P.C.

65 Catechu Tincture, B.P.C.

66 Ceratonia, B.P.C. 1949

67 Charcoal, B.P.C.

68 Chloramine, B.P.C.

69 Chloramphenicol Palmitate, B.P.C.

70 Chloramphenicol Sodium Succinate

71 Chlorhexidine Gluconate

72 Chlorinated Lime. B.P.C.

73 Cholestyramine

74 Clemastine Hydrogen Fumarate

75 Clemizole Hydrochloride

76 Clemizole Tannate

77 Clindamycin Hydrochloride

78 Clonidine Hydrochloride

79 Clopamide

80 Clorexolone

81 Coal Tar, B.P.C.

82 Coal Tar Solution. Strong, B.P.C.

83 Cochineal Tincture, B.P. 1948

84 Coconut Oil, B.P.C.

85 Colaspase

86 Colophony Ointment, B.P.C. 1959

87 Copper Sulphate, B.P.C.

88 Creosote, B. P. C. 1959

89 Cyclothiazide

90 Cycrimine Hydrochloride

91 Cytarabine Hydrochloride

92 Daunorubicin

93 Death Adder Antivenene

94 Debrisoquine

95 Demecarium Bromide

96 Dexamethasone Metasulphobenzoate

97 Dexamethasone Sodium Phosphate

98 Dexchlorpheniramine Maleate

99 Dextrose Polymer

100 Diazoxide

101 Dibenzepin Hydrochloride

102 Dihydroergotamine Mesylate

103 Dihydroergotoxine Mesylate

104 Dihydrostreptomycin Sulphate, B.P. 1958

105 Dimethicone, B.P.C.

106 Dimethindene Maleate

107 Dioctyl Sodium Sulphosuccinate B.P.C.

108 Diphenylpyraline Hydrochloride

109 Diphtheria Vaccine Adsorbed. B.P. Diluted

110 Diphtheria and Tetanus Vaccine Adsorbed, B.P. Diluted

111 Dipyridamole

112 Doxepin Hydrochloride

113 Doxylamine Succinate

114 Droperidol

115 Ephedrine, B.P.C.

116 Epicillin

117 Erythrityl Tetranitrate

118 Erythromycin Ethyl Succinate

119 Erythromycin Gluceptate

120 Erythromycin Lactobionate

121 Ethoxzolamide

122 Ethylidene Dicoumarin

123 Ethylnoradrenaline Hydrochloride

124 Ethyloestrenol

Third Schedule—continued

125 Ferric Hydroxide

126 Ferrous Aminoacetosulphate

127 Ferrous Phosphate Compound, Syrup, B.P.C. 1968

128 Fluclorolone Acetonide

129 Flumethasone Pivalate

130 Fluorometholone

131 Fluorouracil Sodium

132 Fluphenazine Decanoate

133 Fluphenazine Enanthate

134 Flurandrenolone

135 Fusidic Acid

136 Galactomin, Formula No. 17

137 Galactomin, Formula No. 19

138 Gall and Opium Ointment, B.P.C. 1963

139 Gelsemium Tincture, B.P.C.

140 Ginger Syrup, B.P.C.

141 Glibenclamide

142 Glucagon Hydrochloride

143 Glucose and Ketone Indicator

144 Glucose Indicator—Wood

145 Glucose Indicator—Urine

146 Glycerophosphate Compound Syrup, A.P.F. 1964

147 Glycopyrronium Bromide

148 Glymidine

149 Goal’s Milk, Dehydrated

150 Goat’s Milk, Whole (Sterilised)

151 Gramicidin

152 Gualphenesin, B.P.C.

153 Haemodialysis Solutions, B.P.C.

154 Hamamelis Liquid Extract, B.P.C.

155 Heparin Calcium

150 Hexamine Hippurate

157 Hexamine Mandelate

158 Hexocyclium Methylsulphate

159 Hydrargaphen

160 Hydromorphone Hydrochloride

161 Hydroxyurea

162 Hyoscine Butylbromide

163 Hyoscine Methobromide

164 Hyoscyamus Liquid Extract, B.P.C.

165 Hypophosphorous Acid, Dilute, B.P.C. 1963

166 Hypromellose 4500 B.P.C.

167 Ibuprofen

168 Icthammol, B.P.C.

169 Influenza Vaccine—Sub Unit Type

(Desoxycholate Treated)

170 Injection of Amino Acids with Sorbitol and Alcohol

171 Injection of Casein Hydrolysate with Lacvulose and Alcohol

172 Injection of Potassium Chloride with Sodium Lactate and Anhydrous Dextrose

173 Injection of Sodium Chloride with Potassium Chloride, Calcium Chloride and Anhydrous Dextrose

174 Injection of Sodium Chloride with Sodium Lactate and Anhydrous Dextrose

175 Insect Allergen Extract—Bull Ant

176 Insect Allergen Extract—Honey Bee

177 Insect Allergen Extract—Jumper Ant

178 Insect Allergen Extract—Paper Wasp

179 Insulin Injection, specially purified

180 Insulin Isophane Injection, specially purified

181 Insulin Injection, Special P (Pig)

182 Intraperitoneal Dialysis Solutions, B.P.C.

183 Invert Sugar

184 Iron Polymaltose Complex

185 “ ISOMIL ”

186 Isoprenaline Hydrochloride, B.P.C.

187 Isopropamide Iodide

188 “ KETOVITE ” Liquid

189 “ KETOVITE ” Tablets

190 Lactulose

191 Lauryl Dimethyl Benzyl Ammonium Chloride

192 Lavender Oil, Spike. B.P.C. 1968

193 Lead Subacetate Strong Solution, B.P.C.

194 Lemon Oil Terpeneless, B.P.C.

195 Lemon Tincture, B.P. 1958

196 Lipopancreatin

197 Lobelia Ethereal Tincture, B.P.C.

198 Locasol

199 Lofenalac

200 Lypressin

201 Magenta B.P.C.

202 Magnesium-Aluminium Hydroxide

203 Magnesium Hydroxide, B.P.C.

204 Maphenide Acetate

205 Mebeverine Hydrochloride

206 Mebhydrolin Napadisylate, B.P.C. 1968

207 Mecamylamine Hydrochloride, B.P. 1968

208 Medroxyprogesterone Acetate

209 Medrysone

210 Mepenzolate Bromide

211 Mercaptomerin Sodium

212 Mercuric Chloride, B.P.C.

213 Methaqualone Hydrochloride

214 Methdilazine Hydrochloride

215 Methenolone Acetate

216 Methsuximide

217 Methyclothiazide

218 Methylphenobvarbitone B.P.C. 1963

219 Methylprednisolone Acetate

220 Methylprednisolone Sodium Succinate

221 Methysergide Maleate

222 Metoclopramide Hydrochloride

223 Minocycline Hydrochloride

224 Morphine Tartrate

225 Myrrh Tincture, B.P.C.

226 Nalidixic Acid, B.P.C.

227 Nandrolone Hexoxyphenyl Propionate

228 Natamycin

229 Neomycin Undecenoate

230 Nitromin

231 Norgestrel

232 Nutramigen

233 Octatropine Methylbromide

234 Oestradiol Valerate

235 Oestrone, B.P.C. 1954

236 Orange Syrup, B.P.C.

237 Orange Tincture, B.P.C.

238 Oxazepam

239 Oxethazaine

240 Oxprenolol Hydrochloride

241 Oxycodone Pectinate

242 Oxymel B.P.C.

243 Oxymetholone

244 Oxyphenonium Bromide

245 Oxytetracycline

246 Oxytocin

247 Pancreatin Enzyme, U.S.N.F, XIII

248 Pancrelipase

Third Schedule—continued

249 Papaveretum, B.P.C.

250 Paraffin Liquid Light, B.P.C. 1963

251 Paramethasone Acetate

252 Pectin

253 Pempidine Tartrate, B.P. 1968

254 Penicillinase

255 Penicillin Benethamine, B.P.C.

256 Pentacrythritol Tetranitrate, diluted, B.P.C.

257 Pentazocine Lactate

258 Pentobarbitone

259 Pericyazine

260 Pheniramine Maleate

261 Pheniramine Para-Aminosalicylate

262 Phenol Ointment, B.P. 1948

263 Phenoxymethylpenicillin, Benzathine

264 Phenoxymethylpenicillin, Hydrabamine

265 Phensuximide, B.P.C.

266 Phenytoin, B.P.C.

267 Phthalylsulphacetamide

268 Physostigmine, B.P.C.

269 Pilocarpine Hydrochloride, B.P.C.

270 Pipenzolate Bromide

271 Pituitary Hormone, Follicle-stimulating, Human

272 Pituitary Hormone, Growth, Human

273 Pituitary (Posterior Lobe) Powdered, B.P.C.

274 Pizotifen Malate

275 “ PK AID I ”

276 “ PK AID II”

277 Plasma Substitute (Polypeptide)

278 Polyisobutylene

279 Polyoestradiol Phosphate

280 Polyvinyl Alcohol

281Polyvinylpyrrolidone and Vinyl Acetate Copolymer

282 Potassium Chlorate, B.P.C.

283 Potassium Effervescent Tablets

284 Pralidoxime Iodide

285 Prednisolone Acetate

286 Prednisolone Sodium Succinate

287 Prednisolone Steaglate

288 Prednisolone Tertiary Butyl Acetate

289 “ PREGESTIMIL ”

290 Prindolol

291 Procarbazine Hydrochloride

292 Prochlorperazine

293 Proflavine Hemisulphate, B.P.C.

294 Proscillaridin

295 “ PROSOBEE ”

296 Pumilio Pine Oil, B.P.C.

297 Pyrantel Embonate

298 Quillaia Tincture, B.P.C.

299 Quinethazone

300 Quinidine Bisulphate

301 Raspberry Syrup, B.P.C.

302 Rauwolfia Alkaloids

303 Rauwolfia Serpentina, B.P.C.

304 Red Back Spider Antivenene

305 Rolitetracycline

306 Rosemary Oil, B.P.C.

307 Saccharin Tablets, B.P.C.

308 Salicylamide

309 Secbutobarbitone Sodium

310 Senega, Concentrated Infusion, B.P.C.

311 Siberian Fir Oil, B.P.C. 1949

312 Silver Protein, B.P.C. 1968

313 Silver Protein Mild, B.P.C. 1968

314 Snake Bite Antivenene—Polyvalent

315 “ SOBEE ”

316 Sodium Gluconate

317 Sodium Hypochlorite Solution, Strong, B.P.C.

318 Sodium Lactate

319 Sodium Nitroprusside

320 Sodium Tauroglycocholate, B.P.C. 1954

321 Sorbide Nitrate

322 “ SOYALAC ”

323 Spectinomycin Dihydrochloride Pentahydrate

324 Squill Oxymel, B.P.C.

325 Squill Syrup, B.P.C.

326 Squill Tincture, B.P.C.

327 Stanolone

328 Staphylococcus Toxoid, B.P. 1968

329 Stearic Acid, B.P.C.

330 Sterculia, B.P.C.

331 Stilboestrol Diphosphate

332 Stone Fish Antivenene

333 Stramonium Liquid Extract, B.P. 1968

334 Streptokinase

335 Strychnine, B.P.C. 1959

336 Sulphaphenazole, B.P.C. 1968

337 Sulphasalazine

338 Sulphasymazine

339 Sulphurated Potash, B.P.C.

340 Sulphur Sublimed, B.P.C.

341 Surgical Cement

342 Surgical Cement Solvent

343 Tacrine

344 Taipan Antivenene

345 Tartrazine, B.P.C. 1984

346 Terbutaline Sulphate

347 “ TERIC N8 ”

348 Testosterone Decanoate

349 Testosterone Enanthate

350 Testosterone Isocaproate

351 Tetracycline. B.P.C.

352 Thiabendazole, B.P.C.

353 Thiethylperazine Malate

354 Thiethylperazine Maleate

355 Thioguanine

356 Thiopropazate Hydrochloride, B.P.C.

357 Thioridazine

358 Thonzonium Bromide

359 Thonzylamine Hydrochloride.

360 Thyrotrophin

361 Tiemonium Iodide

362 Tiger Snake Antivenene

363 Titanium Dioxide, B.P.C.

364 Tolazamide

365 Tolu Syrup, B.P.C.

366 Triethanolamine, B.P.C.

367 Triglycerides Oil, Medium Chain

368 “ TRIGLYDE ”

369 Trimeprazine Tartrate, B.P.C.

370 Trimetaphan Camsylate, B.P. 1968

371 Trolnitrate Phosphate

372 Vanillin, B.P.C.

373 Vasopressin Tannate

374 Verapamil Hydrochloride

375 Vitamin A

376 Vitamin D

377 “ ZERODOR ”

378 Zinc Gelatin, B.P.C. 1968

379 “ ZOFF ”

FOURTH SCHEDULE Regulation 12

Additives

1 Acetone, B.P.C.

2 Alcohol (95%), B.P.

3 Arachis Oil, B.P.

4 Bismuth Subgallate, B.P.C.

5 Camphor, B.P.

6 Caramel Solution A.P.F.

7 Castor Oil, B.P.

8 Chlorhexidine Acetate, B.P.C.

9 Chlorhexidine Gluconate Solution, B.P.

10 Chloroform, B.P.

11 Cincole, B.P.C.

12 Citronella Oil, B.P.C.

13 Concentrated Anise Water, B.P.C.

14 Concentrated Cinnamon Water, B.P.C.

15 Concentrated Peppermint Water, B.P.

16 Dextrose, B.P.

17 Dilute Alcohols, B.P

18 Ether, Anaesthetic, B.P.

19 Ether, Solvent, B.P.

20 Eucalyptus Oil, B.P.

21 Honey, Purified, B.P.C.

22 Hypromellose 4500, B.P.C.

23 Industrial Methylated Spirit, B.P.

24 Maize Oil, B.P.

25 Methylcellulose 20, B.P.C.

26 Methylcellulose 4500, B.P.C.

27 Olive Oil, B.P.

28 Peppermint Oil, B.P.

29 Saccharin Sodium, B.P.

30 Sodium Thiosulphate, B.P.C.

31 Syrup of Pholcodine Citrate, B.P.C. 1959

32 Turpentine Oil, B.P.

33 Xylene, B.P.C. 1949

FIFTH SCHEDULE Regulation 14

Pharmaceutical Benefits the Prescribing of which is Subject to Conditions and Restrictions

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
1	Acetylcysteine............................	Cystic fibrosis (mucoviscidosis)
2	Aspirin with Paracetamol and Caffeine Tablets	Any disease or condition in a pensioner
3	Acrylic Resin..............................	Ileostomy or colostomy conditions
4	Albumaid XP..............................	With the written authority of the Director-General, phenylketonuria
5	Alprenolol Injection, BP...........	Idiopathic hypertrophic subaortic stenosis
Right ventricular outflow tract obstruction
Dissecting aneurysm (aortic)
Serious arrhythmias
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found
Thyrotoxicosis
6	Alprenolol Tablets, BP..............	Idiopathic hypertrophic subaortic stenosis
Right ventricular outflow tract obstruction
Dissecting aneurysm (aortic)
Hypertension
Serious arrhythmias
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found
Thyrotoxicosis
7	Amantadine Hydrochloride	With the written authority of the Director-General, the treatment of Parkinson’s disease caused otherwise than by treatment with a drug
8	(1) Aminocaproic Acid, BP	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Aminocaproic Acid Injection, BP
9	Aminogran..................................	With the written authority of the Director-General, phenylketonuria
10	Amphotericin B Injection........	Systemic mycoses
a	(1) Ampicillin Capsules, BP	Infections by organisms sensitive to Ampicillin where the infection cannot be safely and effectively treated with sulphonamides or with any of the following administered orally
(2) Ampicillin Injections and Tablets
(3) Ampicillin Trihydrate, BP with Purified Water, BP
	Benzylpenicillin
	Phenoxymethylpenicillin
Phenethicillin
Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Ampicillin
Urinary tract infections where the patient is sensitive to sulphonamides
12	Ascorbic Acid Tablets, B.P.	Any disease or condition in a pensioner
13	Azathioprine...............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Anaemia, autoimmune haemolytic
Arthritis, rheumatoid with Vasculitis or visceral complications
Continuing azathioprine therapy after discharge from an approved hospital
Crohn’s disease
Dermatomyositis
Granulomatosis, Wegener’s
Hepatitis, active, chronic
Lupus erythematosus, systemic
Nephritis

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
Nephrotic syndrome
Organ transplant
Polyarteritis nodosa
Scleroderma
Thrombocytopenic purpura
.	Ulcerative colitis
14	“ BANISH ”.......................	Ileostomy or colostomy conditions
15	Benzoin Compound Tincture, B.P.C., aerosol spray	Ileostomy or colostomy conditions
16	Benzylpenicillin Injection, 5,000,000 units	Bacterial endocarditis or septicaemia
17	Benzylpenicillin Injection, 10,000,000 units	Bacterial endocarditis or septicaemia
Gastrointestinal surgery
18	Betahistine Hydrochloride..............................................	Meniere’s syndrome
19	Betamethasone Acetate with Betamethasone Injection	Alopecia areata
Granuloma, dermal
Intra-articular use
Keloid
Lichen planus hypertrophic
Lichen simplex chronicus
Lupus erythematosus, chronic discoid
Uveitis
With the written authority of the Director-General, pro-operative and post-operative prophylactic therapy for those patients undergoing or recently subjected to steroid therapy
20	Bethanechol Chloride.........	Urinary retention due to a neurogenic atonic bladder
21	Busulphan Tablets, B.P.....	Treatment in malignant neoplasia
22	(1) Calciferol Tablets, Strong, B.P.	With the written authority of the Director-General—
Hypoparathyroidism
(2) Calciferol, B.P.	Osteomalacia following gastrectomy or severe steatorrhoea
Vitamin D-resistant rickets
23	Calcium Carbonate, B.P. with Calcium Lactate-Gluconate	Hypocalcaemia
Hypoparathyroidism
Osteoporosis
24	Calcium Carbonate, B.P. with Citric Acid, B.P., Compound Effervescent Tablets	Hypocalcaemia
Hypoparathyroidism
Osteoporosis
25	Calcium Dioxytetracycline..............................................	Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic
Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets
26	Calcium Folinate................	Antidote to folic acid antagonists
27	Carbamazepine Tablets, B.P.	Epilepsy
Trigeminal neuralgia
28	Carbenicillin Sodium.........	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, infections where positive bacteriological evidence confirms that carbenicillin is the most appropriate Therapeutic agent
29	Carbenoxolone Tablets, B.P.	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, gastric ulcer where a radiological examination or other appropriate tests have confirmed the presence of a gastric ulcer

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
30	(1) Cephalexin Capsules, B.P.	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Cephalexin Tablets, B.P.
(3) Cephalexin, B.P. with Purified Water, B.P.

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephalexin monohydrate is the most appropriate therapeutic agent
31	Cephaloridine..................	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephaloridine is the most appropriate therapeutic agent
32	Cephalothin Sodium......	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephalothin sodium is the most appropriate therapeutic agent
33	Charcoal Tablets.............	Ileostomy or colostomy conditions
34	Chlorambucil Tablets, B.P...............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Anaemia, autoimmune, haemolytic
Arthritis, rheumatoid with vasculitis or visceral complications
Continuing chlorambucil therapy after discharge from an approved hospital
Crohn’s disease
Dermatomyositis
Granulomatosis, Wegener’s
Hepatitis, active, chronic
Lupus erythematosus, systemic
Malignant disease including leukaemia
Nephritis
Nephrotic syndrome
Polyarteritis nodosa
Scleroderma
Thrombocytopenic purpura
Ulcerative colitis
35	Chloramine Deodorant Tablets and Powder	Ileostomy or colostomy conditions
36	(1) Chloramphenicol Capsules, B.P.	Bacterial meningitis
Intraocular infections
(2) Chloramphenicol Injections	Rickettsioses
	Typhoid
(3) Chloramphenicol Oral Suspension	The treatment of other serious infections in a patient where it is established by appropriate bacteriological testing that chloramphenicol is the only suitable antibiotic listed as a pharmaceutical benefit for use in treating the infection in the patient
37	Chlorotrianisene Tablets...............................................	Carcinoma of the prostate
38.	(1) Chlorpromazine Hydrochloride, B.P.	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Chlorpromazine Injection, B.P.	Chorea
	Hyperactive states of organic or toxic delirium
(3) Chlorpromazine Tablets, B.P.	Major psychoses including—
	Major organic psychoses including arteriopathic dementia
Manic-depressive psychosis
Paranoid states
Schizophrenia
Senile dementia

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
Malignant neoplasia (late stage)
Radiation sickness
Severe conduct disorders in patients who have not attained the age of sixteen years
39	Chlortetracycline Hydrochloride	Any disease or condition in a pensioner
40	Cholestyramine...................	With the written authority of the Director-General—
With salt malabsorption associated with ileal resection or proven ileal disease
Pruritus associated with partial biliary obstruction not responding to other therapy
Treatment of severe hypercholesterolemia
41	Clindamycin Hydrochloride	Gram-positive coccal infections where the infection cannot be safely and effectively treated with penicillin, or a derivative of penicillin
42	Clofibrate............................	With the written authority of the Director-General—
Diabetic retinopathy (exudative)
Initial treatment with clofibrate of hyperlipidaemia not responding to dietary therapy
A second or subsequent course of treatment of hyperlipidaemia where significant lowering of serum triglyceride or serum cholesterol subsequent to initial treatment with clofibrate has been established by laboratory report
43	(1) Cloxacillin Sodium, B.P.	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Cloxacillin Capsules, B.P.
(3) Cloxacillin Sodium, B.P. with Purified Water, B.P.	With the written authority of the Director-General, infections where bacteriological evidence confirms the presence of penicillin-resistant staphylococci
Osteomyelitis
44	(1) Codeine Phosphate with Aspirin Soluble Tablets	Any disease or condition in a pensioner
(2) Codeine Phosphate with Aspirin Tablets
(3) Codeine Phosphate with Aspirin and Paracetamol Soluble Tablets
(4) Codeine Phosphate with Aspirin and Paracetamol Tablets
(5) Codeine Phosphate with Aspirin, Paracetamol and Caffeine Tablets
45	Colaspase...........................	Acute leukaemia
Malignant neoplasia
46	Colistin Sulphomethate Sodium, B.P., for injection	Pyocyancus infection, other gram-negative infections where no other drug is effective
47	Cyanocobalamin Injection, B.P.	Pernicious anaemia and other proven Vitamin B 12 deficiencies
Post-gastrectomy treatment
Sub-acute combined degeneration of the cord
Neuroblastoma
48	(1) Cyclophosphamide Tablets, B.P.	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Cyclophosphamide, B.P.	With the written authority of the Director-General—
Anaemia, autoimmune, haemolytic
Arthritis, rheumatoid with vasculitis or visceral complications
Continuing cyclophosphamide therapy after discharge from an approved hospital
Crohn’s disease
Dermatomyositis
Granulomatosis, Wegener’s

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
Hepatitis, active, chronic
Lupus erythematosus, systemic
Malignant disease, including leukaemia
Nephritis
Nephrotic syndrome
Polyarteritis nodosa
Scleroderma
Thrombocytopenic purpura
Ulcerative colitis
48A	Cycloserine Capsules, B.P...	Tuberculosis
49	(1) Cyproheptadine Hydrochloride, B.P.	Allergic rhinitis
Allergic dermatoses
(2) Cyproheptadine Tablets, B.P.	Migraine
50	Cytarabine Hydrochloride....	Acute, leukaemia
Malignant neoplasia
51	Daunorubicin......................	Acute leukaemia
Malignant neoplasia
52	Deodorant Detergent Solution (Lauryldimethyl Benzyl Ammonium Chloride and “TERIC N8”)	Ileostomy or colostomy conditions
53	Desferrioxamine Mesylate ..	Acute iron poisoning
Hepatolenticular degeneration
54	Dexamphetamine Tablets, B.P.	With the written authority of the Director-General—
For the treatment of a patient who has not attained the age of twenty-one years and who is hyperkinetic as a result of brain damage
Narcolepsy
55	(1) Dextromoramide Tablets, B.P.	Treatment in malignant neoplasia
(2) Dextromoramide Tartrate, B.P.
56	Dextrose Polymer...............	With the written authority of the Director-General—
Phenylketonuria
Tube-feeding of infants with swallowing defects
57	Diazoxide...........................	Hypertensive crisis
58	Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride	Vomiting in pregnancy
59	(1) Dihydroergotoxine Mesylate Tablets	For the treatment of patients who have suffered an attack of paralytic poliomyelitis
(2) Dihydroergotoxine Mesylate Injection
60	Dihydrotachysterol.............	With the written authority of the Director-General—
Hypoparathyroidism
Osteomalacia following Gastrectomy or severe steatorrhoea
Vitamin D-resistant rickets
61	Dimethicone Aerosol Spray	Ileostomy or colostomy conditions
62	Dimethicone Creams .......... .	Use with surgical appliances
63	(1) Dioctyl Sodium Sulphosuccinate	Any disease or condition in a pensioner
(2) Dioctyl Sodium Sulphosuccinate with Bisacodyl
(3) Dioctyl Sodium Sulphosuccinate with Danthron
64	Dipyridamole......................	Supplementing, anticoagulants in—
Biopsy proven glomerulonephritis
Microangiopathic renal disease
Renal allograft
Patients with cardiac prosthesis

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
65	Doxycycline Hydrochloride Suspension	Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic
Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets
66	Droperidol..........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
67	(1) Epicillin Capsules	Infections by organisms sensitive to Epicillin where the infection cannot be safely and effectively treated with sulphonamides or with any of the following administered orally—
(2) Epicillin with Purified Water, B.P.
Benzylpenicillin
Phenoxymethylpenicillin
Phenethicillin
Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Epicillin
Urinary tract infections where the patient is sensitive to sulphonamides
68	Ethacrynic Acid................. .	Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome
Fluid retention associated with other conditions and not responding to thiazides
69	Ethyloestrenol.....................	With the written authority of the Director-General—
Intermittent use for corticosteroid-induced osteoporosis
Intermittent use for patients on long-term treatment with corticosteroids
Intermittent use for the relief of pain due to osteoporosis
Osteomalacia following gastrectomy
70	Ferrous Sulphate (Dried), B.P. with Folic Acid, B.P.	Prophylactic use during pregnancy
71	Fludrocortisone Tablets, B.P.	Adrenal cortical hypoplasia including Addison’s disease
Orthostatic hypotension
Salt-losing congenital adrenocortical hyperplasia
Total adrenalectomy
72	Fluorouracil Sodium.......... .	Treatment in malignant neoplasia
73	Fluoxymesterone Tablets, B.P.	Eunuchism
Eunuchoidism
Carcinoma of the breast
With the written authority of the Director-General—
Intermittent use for corticosteroid-induced osteoporosis
Proven aplastic anaemias
74	(1) Fluphenazine Hydrochloride, B.P.	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Fluphenazine Tablets, B.P.	Cholea
(3) Fluphenazine Decanoate	Hyperactive states of organic or toxic delirium
(4) Fluphenazine Enanthate	Major psychoses including—
Major organic psychoses including arteriopathic dementia
Manic-depressive psychosis
Paranoid states
Schizophrenia
Senile dementia
Malignant neoplasia (late stage)
Radiation sickness
75	(1) Folic Acid, B.P.	Cystic fibrosis
(2) Folic Acid Tablets, B.P., 5 mg	Haemolytic anaemia, chronic
	Proven folic acid deficiency
Sprue or the sprue-like syndrome

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
76	Folic Acid Tablets, B.P., 500 μg	Cystic fibrosis
Haemolytic anaemia, chronic
Pregnancy
77	Framycetin Sulphate injection	Sub-conjunctival injection in the treatment of serious ocular inflammation
78	Framycetin Sulphate Tablets	Bowel sterilisation preparatory to major surgery
79	Frusemide Tablets, B.P......	Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome
Fluid retention associated with other conditions and not responding to thiazides
80	Fusidic Acid.......................	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, for use in combination with another antibiotic in the treatment of serious staphylococcal infections confirmed by bacteriological evidence
81	Galactomin Formula No. 17	With the written authority of the Director-General—
Galactosaemia
Conditions needing an extreme, restriction of lactose in the diet of a patient under the age of four years
82	Galactomin Formula No. 19	With the written authority of the Director-General, glucose-galactose malabsorption
83	Gentamicin injection, B.P...............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Infections where positive bacteriological evidence confirms that gentamicin sulphate is the most appropriate antibiotic
Septicaemia including suspected septicaemia
84	Glucose Indicator—Blood..	Diabetes mellitus, where blood sugar levels cannot be determined to be within a satisfactory range by urine testing
Hypoglycaemia of infancy
85	Goat’s Milk Dehydrated.....	With the written authority of the Director-General, cow’s milk allergy in children who have not attained the age of six years
86	Gout’s Milk, Whole (Sterilized)	With the written authority of the Director-General, cow’s milk allergy in children who have not attained the age of six years
87	Griseofulvin Tablets, B.P...............................................	With the written authority of the Director-General, for use in severe tinea infections due to Microsporum Trichophyton or Epidermophyton species which have been proven by laboratory examination or Wood’s Light
88	Halibut Liver Oil Capsules...............................................	Any disease or condition in a pensioner
89	Haloperidol.........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Chorea
Major psychoses including—
Major organic psychoses
Manic psychoses
Paranoid states
Schizophrenia
Malignant neoplasia (late stage)
Radiation sickness
90	Heparin Calcium................	Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
91	Hydrocortisone Acetate Injection, B.P.	Alopecia areata
Granulomata, dermal
Intra-articular use
Keloid
Lichen planus hypertrophic
Lichen simplex chronicus
Lupus erythematosus, chronic discoid
92	Hydrocortisone Sodium Succinate Injection, 100 mg	Acute medical or surgical crisis
Prophylactic therapy before, during and after surgical procedures for patients requiring or recently subjected to steroid therapy
93	Hydrocortisone Sodium Succinate Injection, 250 mg and 500 mg	Any disease or condition in a patient receiving treatment in or at an approved hospital
94	Hydroxocobalamin Injection, B.P.	Pernicious anaemia and other proven Vitamin B12 deficiencies
Post gastrectomy treatment
Sub-acute combined degeneration of the cord
Neuroblastoma
95	Hydroxyurea......................	Any disease or condition in a patient receiving treatment in or at an approved hospital
96	Ibuprofen............................	Rheumatoid arthritis where salicylates are contra-indicated or ineffective
Osteoarthritis where salicylates are contra-indicated or ineffective
97	(1) Idoxuridine Eye Drops ..	Infections caused by Herpes Simplex Virus or by Vaccinia Virus
(2) Idoxuridine Eye Ointment
98	Influenza Vaccine .............	For prophylaxis of—
children who have attained the age of one year but have not attained the age of five years
pensioners
persons suffering front any severe debilitating disease, chronic heart disease or chronic pulmonary disease
99	Insect Allergen Extract—Bull Ant	Severe constitutional reaction to bull ant stings
100	Insect Allergen Extract—Honey Bee	Severe constitutional reaction to bee stings
101	Insect Allergen Extract—Jumper Ant	Severe constitutional reaction to jumper ant stings
102	Insect Allergen Extract—Paper Wasp	Severe constitutional reaction to wasp stings
103	“ ISOMIL ”........................	With the written authority of the Director-General—
Cow’s milk allergy in children who have not attained the age of six years
Galactosaemia
Homocystinuria
Lactose intolerance
104	Isoprenaline Hydrochloride Tablets, 30 mg	Stokes-Adams Syndrome
105	Kanamycin Injection, B.P............................................... .	Infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the most appropriate antibiotic
Septicaemia, including suspected septicaemia
106	(1) “ KETOVITE ” Liquid ..	With the written authority of the Director-General—
(2) ” KETOVITE ” Tablets ..	Galactosaemia
Persistent monosaccharide intolerance
Phenylketonuria
Tyrosinosis (hereditary)
107	Lactulose............................ .	Hepatic coma or pre-coma (chronic portosystemic encephalopathy)

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
108	(1) Levodopa Capsules, B.P.	With the written authority of the Director-General, treatment of Parkinson’s Disease
(2) Levodopa Tablets, B.P.
109	(1) Lignocaine Hydrochloride, B.P., Injection	Cardiac arrhythmias
(2) Lignocaine Hydrochloride Injection, B.P.
110	(1) Lincomycin Hydrochloride B.P.	Anaerobic infections
Osteomyelitis

(2) Lincomycin Capsules, B.P.
111	Liothyronine Tablets, B.P..	Myxoedema
112	Lithium Carbonate Tablets, B.P.	With the written authority of the Director-General, manic depression
113	Locasol...............................	With the written authority of the Director-General—
Hypercalcemia in children who have not attained the age of two years
Osteopetrosis
114	Lofenalac............................	With the written authority of the Director-General, phenylketonuria
115	Lypressin Nasal Spray.......	Diabetes insipidus
116	Maphenide Acetate.............	Any disease or condition in a patient receiving treatment in or at an approved hospital
117	Medroxyprogesterone Acetate Tablets, 2.5 mg	Precocious puberty
Turner’s syndrome
118	Medroxyprogesterone Acetate Tablets, 100 mg	Precocious puberty
Turner’s syndrome
119	(1) Medroxyprogesterone Acetate Tablets, 100 mg	Malignant neoplasia
(2) Medroxyprogesterone, Acetate Injections, 50 mg in 1 ml	Precocious puberty
(3) Medroxyprogesterone Acetate Injections, 150 mg in 1 ml
120	Megestrol Acetate, B.P. with Ethinyloestradiol, B.P.	Fertility control in females who have severe acne or severe hirsutism which has been aggravated by other oral contraceptives
Sexual infantilism in females
Stein-Leventhal syndrome
121	Melphalan Tablets, B...........	Treatment in malignant neoplasia
122	Mercaptopurine Tablets, B.P.	Allergic granulomatous angiitis
Lupus erythematosus
Nephrotic syndrome
Periarteritis (nodosa)
Treatment in malignant neoplasia
123 ‘	Methacycline Hydrochloride, B.P.	Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic
Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets
124	(1) Methandienone Tablets, B.P.	With the written authority of the Director-General—
Intermittent use for corticosteroid-induced osteoporosis
	(2) Methenolone Acetate
Intermittent use for patients on long-term treatment with corticosteroids
Intermittent use for the relief of pain due to osteoporosis
125	Methicillin Sodium, B.P., for Injection	Proven or suspected staphylococcal septicaemia

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
126	(1) Methotrexate Tablets...............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Methotrexate Injection
With the written authority of the Director-General—
Continuing methotrexate therapy after discharge from an approved hospital
Malignant neoplasia
Pemphigus vulgaris
Psoriasis, severe, generalised
127	Methylprednisolone Acetate Retention Enema	With the written authority of the Director-General—
Colitis, ulcerative, proven by sigmoidoscopy or radiological report
Proctitis, proven by sigmoidoscopy
128	Methylprednisolone Acetate Injection	Intra-articular use
129	Methyltestosterone Tablets, B.P., 5 mg	Hypogonadism in patients who have not attained the age of sixteen years
130	(1) Methyltestosterone Tablets, B.P., 25 mg or 50 mg	Carcinoma of the breast
Eunuchism
(2) Methyltestosterone, B.P.	Eunuchoidism
Klinefelter’s syndrome (seminiferous tubule dysgenesis)
131	Methysergide Maleate ..	Carcinoid syndrome
Treatment of severe recalcitrant migraine where other treatment has failed
132	Metyrapone Capsules, B.P.. . .	Any disease or condition in a patient receiving treatment in or at an approved hospital
133	Morphine Sulphate, B.P. with Tacrine Tablets	Severe intractable pain
134	Mustine Hydrochloride Injection	Treatment in malignant neoplasia
135	Nalidixic Acid .. ..	Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Nalidixic Acid or where the patient is sensitive to sulphonamides
136	Nandrolone Decanoate	Carcinoma of the breast
With the written authority of the Director-General—
Intermittent use for corticosteroid-induced osteoporosis
Intermittent use for patients on long-term treatment with corticosteroids
Intermittent use for the relief of pain due to osteoporosis
Severe osteoporosis due to proven pancreatitis
137	Nandrolone Hexoxyphenyl Propionate	Carcinoma of the breast
With the written authority of the Director-General—
Intermittent use for corticosteroid-induced osteoporosis
Intermittent use for patients on long-term treatment with corticosteroids
Intermittent use for the relief of pain due to osteoporosis
138	Nandrolone Phenylpropionate Injection, B.P.	Carcinoma of the breast
With the written authority of the Director-General—
Intermittent use for corticosteroid-induced osteoporosis
Intermittent use for the relief of pain due to osteoporosis
139	Neomycin Sulphate Powder	With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis)
140	Neomycin Tablets, B.P. .....	Dowel sterilization preparatory to major surgery
Encephalopathy, hepatic
Enteropathogenic E. coli infections in infants
141	Nicotinic Acid Tablets, B.P.	Any disease or condition in a pensioner
142	(1) Nitrofurantoin Tablets, B.P.	Urinary tract Infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Nitrofurantoin or where the patient is sensitive to sulphonamides
(2) Nitrofurantoin Oral Suspension

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
143	Nitromin..............................	Treatment of malignant neoplasia
144	Norethisterone Acetate, B.P. Tablets, 10 mg	Carcinoma of the breast
Carcinoma of the endometrium
145	Norethisterone Acetate, B.P., Tablets, 2.5 mg	Endometriosis
Metropathia haemorrhagica
Precocious puberty
Turner’s Syndrome
146	Norethisterone Tablets, B.P.	Endometriosis
Metropathia haemorrhagica
Precocious puberty
Turner’s syndrome
147	Nutramigen..........................	With the written authority of the Director-General—
Cow’s milk allergy in children who have not attained the age of six years
Cystic fibrosis (mucoviscidosis)
Galactosaemia
Lactose intolerance
148	Oxprenolol Hydrochloride Tablets	Dissecting aneurysm (aortic)
Hypertension
Idiopathic hypertrophic subaortic stenosis
Right ventricular outflow tract obstruction
Serious arrhythmias
Thyrotoxicosis
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found
149	Oxprenolol Hydrochloride Injection	Idiopathic hypertrophic subaortic stenosis
Right ventricular outflow tract obstruction
Dissecting aneurysm (aortic)
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found
Serious arrhythmias
Thyrotoxicosis
150	Oxycodone Pectinate...........	Treatment in malignant neoplasia
151	Oxymetholone.....................	With the written authority of the Director-General—
Proven aplastic anaemias
Myelosclerosis
152	Oxytetracycline Capsules, B.P., 100 mg	Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic
153	Oxytetracycline Hydrochloride, B.P., Ointment	Any disease or condition in a pensioner
154	(1) Pancreatin, B.P.	Cystic fibrosis (mucoviscidosis)
(2) Pancreatin Enzyme 4X U.S.N.F.XIII	Following pancreatico-duodenectomy
	Pancreatic steatorrhoea
(1) Pancrelipase
155	(1) Paraffin Liquid Emulsion	Any disease or condition in a pensioner
(2) Paraffin Liquid Emulsion with Phenolphthalein
156	Penicillamine........................	With the written authority of the Director-General—
Acute heavy metal intoxication
Cystinosis
Cystinuria with calculus formation
Haemoglobinuria, paroxysmal cold
Wilson’s disease (hepatolenticular degeneration)
157	(1) Pericyazine Mesylate.....	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Pericyazine.....................
Chorea
Hyperactive states of organic or toxic delirium
Major psychoses, including—
Major organic psychoses including arteriopathic dementia

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
Manic-depressive psychosis
Paranoid states
Schizophrenia
Senile dementia
Malignant neoplasia (late stage)
Radiation sickness
Severe conduct disorders in patients who have not attained the age of sixteen years
158	Phenobarbitone Tablets, B.P., 60 mg and 100 mg	Epilepsy
159	Phenobarbitone Sodium Tablets, B.P., 60 mg and 100 mg	Epilepsy
160	Phytomenadione Injection, 10 mg per ml	Antidote to anticoagulants
Haemorrhagic diathesis associated with malabsorption
161	Phytomenadione Injection, B.P., 1 mg in 1 ml	Antidote to anticoagulants
Haemorrhagic diathesis associated with malabsorption
Suspected cerebral trauma of the new born
Haemorrhagic disease of the new born
162	Pituitary, Posterior Lobe, Insufflation	Diabetes insipidus
163	Pizotifen Malate...................	The treatment of severe migraine in a patient whoso attacks of migraine do not respond to treatment by other therapeutic agents
164	(1) “ PK AID I ”	With the written authority of the Director-General, phenylketonuria
(2) “ PK AID II ”
165	Plasma Substitute (Polypeptide)	Any disease or condition in a patient receiving treatment in or at an approved hospital
166	Polyisobutylene...................	Ileostomy or colostomy conditions
167	Polymyxin B. Sulphate Powder	With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis)
168	Polyoestradiol Phosphate ..	Carcinoma of the breast
Carcinoma of the prostate
169	Polyvinylpyrrolidone and Vinyl Acetate Copolymer	Ileostomy and colostomy conditions
170	(1) Practolol Injection, B.P.	Dissecting aneurysm (aortic)
(2) Practolol Tablets, B.P....	Idiopathic hypertrophic subaortic stenosis
Right ventricular outflow tract obstruction
Serious arrhythmias
Thyrotoxicosis
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic, receptor blocking agents
171	Prednisolone Sodium Phosphate Retention Enema and Suppository	With the written authority of the Director-General—
Ulcerative colitis proven by sigmoidoscopy or radiological report
Proctitis proven by sigmoidoscopy
172	(1) Prednisolone Acetate Injection	Intra-articular use
(2) Prednisolone Butyl Acetate Injection
173	Prednisolone Acetate with Phenylephrine Hydrochloride, B.P.	Corneal grafts
Uveitis
174	Prednisolone Sodium Phosphate Injection, B.P.	Acute medical or surgical crisis
Prophylactic therapy before, during and after surgical procedures for patients requiring or recently subjected to steroid therapy
175	Prednisolone Sodium Succinate Injection	Acute medical or surgical crisis
Prophylactic therapy before, during and after surgical procedures for patients requiring or recently subjected to steroid therapy

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
176	“PREGESTIMIL”...............	With the written authority of the Director-General—
Cystic fibrosis
Multiple disaccharidase deficiency
177	Prindolol Injection...............	Dissecting, aneurysm (aortic)
Idiopathic hypertrophic subaortic stenosis
Right ventricular outflow tract obstruction
Serious arrhythmias
Thyrotoxicosis
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found
178	Prindolol Tablet...................	Dissecting aneurysm (aortic)
Hypertension
Idiopathic hypertrophic subaortic stenosis
Right ventricular outflow tract obstruction
Serious arrhythmias
Thyrotoxicosis
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found
179	Procarbazine Hydrochloride	Treatment in malignant neoplasia
180	Promethazine Theoclate Tablets, B.P.	Vomiting in pregnancy
181	Propranolol Injection, B.P.	Dissecting aneurysm (aortic)
Idiopathic hypertrophic subaortic stenosis
Right ventricular outflow tract obstruction
Serious arrhythmias
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found
Thyrotoxicosis
182	Propranolol Tablets, B.P.....	Dissecting aneurysm (aortic)
Hypertension
Idiopathic hypertrophic subaortic stenosis
Right ventricular outflow tract obstruction
Serious arrhythmias
The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found
Thyrotoxicosis
183	Proscillaridin........................ .	Patients intolerant of oral forms of Digoxin and Lanatoside C
184	“PROSOBEE”.....................	With the written authority of the Director-General—
Cow’s milk allergy in children who have not attained the age of six years
Galactosaemia
Homocystinuria
Lactose intolerance
185	Pyrazinamide.......................	Any disease or condition in a patient receiving treatment in or at an approved hospital
186	Pyridoxine Hydrochloride Tablets	Anaemia proved to be responsive to Pyridoxine
Convulsions responsive to Pyridoxine
Homocystinuria
Primary hyperoxaluria
Radiation sickness
Sideroblastic (refractory) anaemia
Treatment and prophylaxis of peripheral neuritis caused or likely to be caused by isoniazid therapy
187	Riboflavine Tablets.............	Any disease or condition in a pensioner
188	Senna Tablets, B.P..............	Any disease or condition in a pensioner

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
189	“ SOBEE ”...........................	With the written authority of the Director-General—
Cow’s milk allergy in children who have not attained the age of six years
Galactosaemia
Homocystinuria
Lactose intolerance
190	Sodium Fusidate.................. .	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, for use in combination with another antibiotic in the treatment of serious staphylococcal infections confirmed by bacteriological evidence
191	“ SOYALAC ”....................	With the written authority of the Director-General—
Cow’s milk allergy in children who have not attained the age of six years
Galactosaemia
Homocystinuria
Lactose intolerance
192	Spironolactone Tablets, B.P.	To supplement other diuretics when these have proved inadequate
Myasthenia gravis
Primary hyperaldosteronism
Secondary hyperaldosteronism
193	Stanolone ............................	Carcinoma of the breast
With the written authority of the Director-General—
Intermittent use for corticosteroid-induced osteoporosis
Intermittent use for patients on long-term treatment with corticosteroid
Intermittent use for the relief of pain due to osteoporosis
194	Sterculia...............................	Ileostomy or colostomy conditions
195	Stilboestrol Diphosphate.....	Carcinoma of the prostate
196	Streptokinase.......................	Any disease or condition in a patient receiving treatment in or at an approved hospital
197	Sulphasalazine.....................	Ulcerative colitis
198	(1) Surgical Cement	Ileostomy or colostomy conditions
(2) Surgical Cement Solvent	For use with surgical appliances
199	(1) Testosterone, Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate	Carcinoma of the breast
Eunuchism
Eunuchoidism
Klinefelter’s syndrome (seminiferous tubule dysgenesis)
(2) Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate
(3) Testosterone Implants, B.P.
(4) Testosterone Enanthate
(5) Testosterone Propionate Injection, B.P.
200	Tetracosactrin Acetate, B.P.	With the written authority of the Director-General—
Hypsarrhythmia
Multiple sclerosis acute exacerbation
Severe asthma in children where there is evidence of growth suppression produced by corticosteroids
Status asthmaticus
Treatment of patients who are being withdrawn from long-term corticosteroid therapy

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
201	Tetracosactrin Zinc Injection, B.P.	With the written authority of the Director-General—

Hypsarrhythmia
Multiple sclerosis, acute exacerbation
Severe asthma in children where there is evidence of growth suppression produced by corticosteroids
Status asthmaticus
Treatment of patients who are being withdrawn from long-term corticosteroid therapy
202	Tetracycline Capsules, B.P., 100 mg	Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic
203	Tetracycline Hydrochloride, B.P., Syrup	Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic
Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets
204	Tetracycline Hydrochloride with Nystatin, Capsules, 100 mg, 125,000 units	Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic
205	Tetracycline Hydrochloride with Nystatin, Syrups	Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic
Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets
206	Tetracycline with a buffering agent, Capsules, 100 mg	Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic
207	Tetracycline with a buffering, agent, Syrups	Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic
Treatment of patients who have attained the age of eight years and are unable to swallow either capsules or tablets
208	Tetracycline with a buffering agent and Amphotericin B	Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic
Treatment of patients who have attained the age of eight years and who are unable to swallow either capsules or tablets
209	Tetracycline with a buffering agent and Nystatin, B.P., Capsules, 100 mg, 125,000 units	Conditions where tetracycline, or a derivative of tetracycline, is the only appropriate antibiotic
210	Thiamine Hydrochloride Tablets, B.P.	Any disease or condition in a pensioner
211	Thioguanine......................... .	Leukaemia
212	Thiopropazate Hydrochloride	Willi the written authority of the Director-General—
Chorea
Oral dyskinesia.
Phenothiazine induced choreo-athetosis
213	(1) Thioridazine	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Thioridazine Tablets, B.P.
Chorea
Hyperactive states of organic or toxic delirium
Major psychoses including—
Major organic psychoses including arteriopathic dementia
Manic-depressive psychosis
Paranoid states
Schizophrenia
Senile dementia
Malignant neoplasia (late stage)
Radiation sickness
Severe conduct disorders in patients who have not attained the age of sixteen years

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restriction as to the person for whose treatment it may be prescribed) for supply under Part VII of the Act
214	Thyrotrophin........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
215	Triamcinolone Acetonide Injection	Alopecia areata
Granulomata, dermal
Keloid
Lichen planus hypertrophic
Lichen simplex chronicus
Lupus erythematosus, chronic discoid
216	(1) Trifluoperazine Hydrochloride, B.P.	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Trifluoperazine Tablets, B.P.	Chorea
	Hyperactive states of organic or toxic delirium
Major psychoses including—
Major organic psychoses including arteriopathic dementia
Manic-depressive psychosis
Paranoid slates
Schizophrenia
Senile dementia
Malignant neoplasia (late stage)
Radiation sickness
Severe conduct disorders in patients who have not attained the age of sixteen years
217	Triglycerides Oil, Medium Chain	With the written authority of the Director-General, proven malabsorption
218	Triglyde...............................	With the written authority of the Director-General, proven malabsorption
219	Trimethoprim with Sulphamethoxazole	Infections by organisms sensitive to Trimethoprim with Sulphamethoxazole where, the infection cannot be safely and effectively treated with other sulphonamides or with any of the following administered orally:—
Benzylpenicillin
Phenoxymethylpenicillin
Phenethicillin
Ocular surgery
Urinary tract infections by organisms where other sulphonamide treatment has proved Ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Trimethoprim with Sulphamethoxazole
220	Vancomycin Hydrochloride.............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
221	Verapamil Hydrochloride.............................................	Cardiac arrythmias
222	(1) Vinblastine Sulphate.............................................	Treatment in malignant neoplasia
(2) Vincristine Sulphate
223	Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin  D Tablets and Capsules	Any disease or condition in a pensioner
224	“ ZERODOR ”....................	Ileostomy or colostomy conditions
225	“ ZOFF ”.............................	Ileostomy or colostomy conditions
For use with surgical appliances

       

Printed by Authority by the Government Printer of Australia